APA (7th ed.) Citation

Pfau, M., Fassnacht-Riederle, H., Becker, M. D., Graf, N., & Michels, S. (2015). Clinical outcome after switching therapy from ranibizumab and/or bevacizumab to aflibercept in central retinal vein occlusion. Ophthalmic research, 54(3), . https://doi.org/10.1159/000439223

Chicago Style (17th ed.) Citation

Pfau, Maximilian, Heidi Fassnacht-Riederle, Matthias D. Becker, Nicole Graf, and Stephan Michels. "Clinical Outcome After Switching Therapy from Ranibizumab And/or Bevacizumab to Aflibercept in Central Retinal Vein Occlusion." Ophthalmic Research 54, no. 3 (2015). https://doi.org/10.1159/000439223.

MLA (9th ed.) Citation

Pfau, Maximilian, et al. "Clinical Outcome After Switching Therapy from Ranibizumab And/or Bevacizumab to Aflibercept in Central Retinal Vein Occlusion." Ophthalmic Research, vol. 54, no. 3, 2015, https://doi.org/10.1159/000439223.